Home > PJ (current issue) > News / News Centre | Search

PJ Online homeThe Pharmaceutical Journal
Vol 276 No 7392 p307-314
18 March 2006

This section
Reprint   Photocopy

PDF 190K, Acrobat Reader

News summary

DIARY   Branch meetings   Future Events   Conferences

307 New Controlled Drug prescribing rules introduced New arrangements for supplying Controlled Drugs in England are to be introduced on 1 April ...more

307 Prescription charges in England to increase Prescription charges in England are to rise by 15p, slightly below inflation, to £6.65 on 1 April. At the same time, the cost of prepayment certificates will rise to £34.65 for four months and £95.30 for a year ...more

307 Independent prescribing set to become an enhanced service Independent prescribing by community pharmacists in England will be recognised as an enhanced service from 1 May. However, it is unlikely that services will be able to start that soon because training courses necessary for pharmacists to qualify as independent prescribers have yet to be approved ...more

307 Six clinical trial patients admitted to critical care Six patients involved in a Phase 1 clinical trial of a drug being developed for leukaemia, rheumatoid arthritis and mutliple sclerosis were admitted to critical care this week ...more

308 Standards set for safe medicine use in hospitals Standards for the safe use of medicines in hospitals in Scotland are set out in a report published last week ...more

308 Scottish Medicines Consortium offers more advice for NHS Scotland Lumiracoxib (Prexige), a selective cyclo-oxygenase 2 (COX-2) inhibitor, is one of four products that have been approved by the Scottish Medicines Consortium for use within NHS Scotland ...more

308 NHS can be powerful force for regeneration, says the Government NHS organisations can be a powerful force in regenerating local communities, Health Secretary Patricia Hewitt told participants at the UK Public Health Association's annual public health forum this week ...more

309 Atherosclerosis reversed by intensive statin therapy In the first study to show regression of atherosclerosis with lipid lowering, two years' treatment with 40mg rosuvastatin (Crestor) achieved reduction in plaque volume in coronary arteries ...more

309 New Society CD inspections to start on 1 April Royal Pharmaceutical Society inspections of the handling of Controlled Drugs by community pharmacies will start on 1 April ...more

309 East London contractors form a new LPC Pharmacy contractors in London's City and Hackney Primary Care Trust area have decided to break away from North East London Local Pharmaceutical Committee and set up a new LPC for themselves ...more

309 New support from UniChem Tailored information about recruitment, induction and people management has been developed for community pharmacists by UniChem ...more

309 Boots invests in small stores Boots Group announced a £400m investment programme this week ...more

310 Perceptions of whether asthma is chronic can affect compliance Asking patients with asthma whether they believe they have the disease all the time can effectively identify those who do not manage their condition as a chronic disease, a US study has found ...more

310 Information may be as crucial as therapy Information about self care could prove to be as important to patient outcomes as medical tests, drugs and other treatments, the founder of the US Prescribing Information to Patients programme argued at a Patient Information Forum conference in Manchester last month ...more

310 Maintain SSRIs in the elderly Recurrence of depression in individuals over 70 years of age can be prevented by maintaining antidepressant treatment, according to the results of a new study ...more

311 Medigas waives rental charges for F and IF cylinders Medigas will waive rental charges for F and IF cylinders, the company announced this week ...more

311 Pharmacy “tremendous” over oxygen crisis, says health minister Community pharmacy's response to the recent oxygen crisis has been acknowledged as “tremendous” by Liam Byrne, Parliamentary Under-Secretary of State for Health ...more

311 Strategy launched for care of patients with GI disorders A blueprint to provide a strategy for the future care of patients with gastrointestinal disorders has been drawn up by the British Society of Gastroenterology ...more

311 MeReC considers dyspepsia Treatment options for dyspepsia are reviewed in the latest issue of MeReC Briefing ...more

311 Alzheimer's disease Antihypertensive medicines may reduce the risk of developing Alzheimer's disease, a study published online has suggested ...more

312 CHARISMA study clarifies when to use clopidogrel Clopidogrel (Plavix) plus low-dose aspirin reduces cardiovascular events and deaths in patients with vascular disease compared with aspirin alone, a new study confirms ...more

312 Abciximab reduces events in PCI patients Abciximab (ReoPro) reduces the risk of events in patients with non-ST-segment elevation acute coronary syndromes (ACS) undergoing percutaneous coronary intervention (PCI) even after pretreatment with 600mg of clopidogrel (Plavix), a new study has shown ...more

312 Fondaparinux may help some myocardial infarction patients Fondaparinux, a factor Xa inhibitor, is effective in reducing mortality and reinfarction in patients with acute ST-segment elevation myocardial infarction (STEMI), according to a study presented at the American College of Cardiology annual scientific session in Atlanta, Georgia ...more

312 Folic acid and B vitamins do not reduce CV events Reducing elevated homocysteine levels with folic acid and B vitamins fails to reduce cardiovascular events, two studies reported at the American College of Cardiology annual scientific session in Atlanta, Georgia, show ...more

313 Developing vaccines to prevent cancers is the “ultimate aim” Developing vaccines to prevent virus-associated cancers is the “ultimate aim” and an area of ongoing and long-term research, according to a Cancer Research UK document, released by the charity this week ...more

313 Fewer than one in every 14 orphan drug applications is approved Developers of orphan drugs need more support from governments, the authors of a paper analysing European Medicines Agency (EMEA) approval data have concluded ...more

313 Tailoring azathioprine doses based on genetics beneficial in eczema Azathioprine is an effective and well tolerated adjunctive treatment for moderate-to-severe atopic eczema, researchers suggest ...more

313 Innovation goes online NHS Ennovations has been launched, providing an online platform for the sale and development of innovative products and services ...more

313 Face masks for flu A review by the Health Protection Agency found no evidence of benefit for issuing face masks to the public in the event of an influenza pandemic, health minister Rosie Winterton said this week. However, in a Parliamentary written reply she said that the evidence will be regularly reviewed ...more


R&D news

314 Treatment modifies Alzheimer's disease pathology Treatments that modify the pathology of Alzheimer's disease, rather than simply treating the symptoms, may be approaching human trials, the authors of a study in mice suggest ...more

314 Antibiotic helps patients with irritable bowels A rifamycin-derived antibiotic improves abdominal bloating and flatulence in individuals with irritable bowel syndrome (IBS), according to a recent study ...more

314 New lease of life for drug to treat Parkinson's disease? Glial-derived neurotrophic factor (GDNF) — a drug that was being developed to treat Parkinson's disease but was withdrawn in 2004 due to safety concerns — may be given a second chance ...more

314 Antibody increases bone density in postmenopausal women Bone mineral density in postmenopausal women can be increased by a human monoclonal antibody, research suggests ...more

Back to Top


©The Pharmaceutical Journal